vs
Cytek Biosciences, Inc.（CTKB）与Orange County Bancorp, Inc.（OBT）财务数据对比。点击上方公司名可切换其他公司
Cytek Biosciences, Inc.的季度营收约是Orange County Bancorp, Inc.的1.9倍（$62.1M vs $33.0M），Orange County Bancorp, Inc.净利率更高（37.6% vs -70.9%，领先108.6%），Orange County Bancorp, Inc.同比增速更快（20.6% vs 8.1%），Orange County Bancorp, Inc.自由现金流更多（$41.3M vs $-1.8M），过去两年Cytek Biosciences, Inc.的营收复合增速更高（17.7% vs 14.3%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
奥兰治县银行控股公司注册于美国特拉华州，主要在纽约州开展业务，为个人消费者、小微企业及中型企业客户提供全面的零售与商业银行服务，涵盖存款账户、各类贷款、财富管理解决方案等金融产品。
CTKB vs OBT — 直观对比
营收规模更大
CTKB
是对方的1.9倍
$33.0M
营收增速更快
OBT
高出12.5%
8.1%
净利率更高
OBT
高出108.6%
-70.9%
自由现金流更多
OBT
多$43.1M
$-1.8M
两年增速更快
CTKB
近两年复合增速
14.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $33.0M |
| 净利润 | $-44.1M | $12.4M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 41.4% |
| 净利率 | -70.9% | 37.6% |
| 营收同比 | 8.1% | 20.6% |
| 净利润同比 | -557.1% | 73.5% |
| 每股收益（稀释后） | — | $0.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBOBT
| Q4 25 | $62.1M | $33.0M | ||
| Q3 25 | $52.3M | $33.7M | ||
| Q2 25 | $45.6M | $32.5M | ||
| Q1 25 | $41.5M | $28.0M | ||
| Q4 24 | $57.5M | $27.4M | ||
| Q3 24 | $51.5M | $27.1M | ||
| Q2 24 | $46.6M | $27.9M | ||
| Q1 24 | $44.9M | $25.3M |
净利润CTKBOBT
| Q4 25 | $-44.1M | $12.4M | ||
| Q3 25 | $-5.5M | $10.0M | ||
| Q2 25 | $-5.6M | $10.5M | ||
| Q1 25 | $-11.4M | $8.7M | ||
| Q4 24 | $9.6M | $7.2M | ||
| Q3 24 | $941.0K | $3.2M | ||
| Q2 24 | $-10.4M | $8.2M | ||
| Q1 24 | $-6.2M | $9.3M |
毛利率CTKBOBT
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBOBT
| Q4 25 | -9.0% | 41.4% | ||
| Q3 25 | -17.6% | 38.6% | ||
| Q2 25 | -23.3% | 41.9% | ||
| Q1 25 | -36.1% | 40.3% | ||
| Q4 24 | 5.2% | 32.8% | ||
| Q3 24 | -8.2% | 14.8% | ||
| Q2 24 | -18.3% | 36.6% | ||
| Q1 24 | -23.9% | 45.9% |
净利率CTKBOBT
| Q4 25 | -70.9% | 37.6% | ||
| Q3 25 | -10.5% | 29.7% | ||
| Q2 25 | -12.2% | 32.2% | ||
| Q1 25 | -27.5% | 31.1% | ||
| Q4 24 | 16.8% | 26.2% | ||
| Q3 24 | 1.8% | 11.8% | ||
| Q2 24 | -22.4% | 29.4% | ||
| Q1 24 | -13.8% | 36.7% |
每股收益（稀释后）CTKBOBT
| Q4 25 | — | $0.94 | ||
| Q3 25 | — | $0.75 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | — | $0.77 | ||
| Q4 24 | — | $0.64 | ||
| Q3 24 | — | $0.28 | ||
| Q2 24 | — | $0.73 | ||
| Q1 24 | — | $0.82 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $341.7M | $284.4M |
| 总资产 | $461.5M | $2.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTKBOBT
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
股东权益CTKBOBT
| Q4 25 | $341.7M | $284.4M | ||
| Q3 25 | $378.6M | $270.1M | ||
| Q2 25 | $377.6M | $252.6M | ||
| Q1 25 | $379.6M | $201.3M | ||
| Q4 24 | $395.7M | $185.5M | ||
| Q3 24 | $385.5M | $193.1M | ||
| Q2 24 | $389.1M | $177.5M | ||
| Q1 24 | $392.6M | $168.7M |
总资产CTKBOBT
| Q4 25 | $461.5M | $2.7B | ||
| Q3 25 | $494.9M | $2.6B | ||
| Q2 25 | $493.3M | $2.6B | ||
| Q1 25 | $482.6M | $2.6B | ||
| Q4 24 | $499.5M | $2.5B | ||
| Q3 24 | $491.2M | $2.5B | ||
| Q2 24 | $483.7M | $2.5B | ||
| Q1 24 | $492.1M | $2.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $43.8M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $41.3M |
| 自由现金流率自由现金流/营收 | -2.9% | 125.1% |
| 资本支出强度资本支出/营收 | 1.6% | 7.6% |
| 现金转化率经营现金流/净利润 | — | 3.53× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $69.6M |
8季度趋势，按日历期对齐
经营现金流CTKBOBT
| Q4 25 | $-771.0K | $43.8M | ||
| Q3 25 | $-3.9M | $30.2M | ||
| Q2 25 | $108.0K | $-5.0M | ||
| Q1 25 | $-125.0K | $4.8M | ||
| Q4 24 | $2.0M | $34.6M | ||
| Q3 24 | $13.2M | $10.2M | ||
| Q2 24 | $6.2M | $9.3M | ||
| Q1 24 | $4.0M | $2.3M |
自由现金流CTKBOBT
| Q4 25 | $-1.8M | $41.3M | ||
| Q3 25 | $-4.6M | $29.6M | ||
| Q2 25 | $-1.5M | $-5.7M | ||
| Q1 25 | $-974.0K | $4.3M | ||
| Q4 24 | $1.1M | $32.9M | ||
| Q3 24 | $12.2M | $10.0M | ||
| Q2 24 | $5.2M | $9.2M | ||
| Q1 24 | $3.4M | $2.0M |
自由现金流率CTKBOBT
| Q4 25 | -2.9% | 125.1% | ||
| Q3 25 | -8.7% | 87.8% | ||
| Q2 25 | -3.2% | -17.5% | ||
| Q1 25 | -2.3% | 15.5% | ||
| Q4 24 | 1.9% | 120.0% | ||
| Q3 24 | 23.7% | 36.7% | ||
| Q2 24 | 11.0% | 32.8% | ||
| Q1 24 | 7.6% | 7.9% |
资本支出强度CTKBOBT
| Q4 25 | 1.6% | 7.6% | ||
| Q3 25 | 1.3% | 1.8% | ||
| Q2 25 | 3.5% | 2.3% | ||
| Q1 25 | 2.0% | 1.8% | ||
| Q4 24 | 1.6% | 6.3% | ||
| Q3 24 | 2.0% | 1.1% | ||
| Q2 24 | 2.3% | 0.4% | ||
| Q1 24 | 1.3% | 1.0% |
现金转化率CTKBOBT
| Q4 25 | — | 3.53× | ||
| Q3 25 | — | 3.01× | ||
| Q2 25 | — | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | 0.21× | 4.83× | ||
| Q3 24 | 14.05× | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
OBT
暂无分部数据
